Virtual Cardiovascular Nursing Symposium Schedule
All times are listed in Central Time.
|WEDNESDAY, MAY 20|
|Start at 11:00 AM ET, 10:00 AM CT, 9:00 AM MT, 8:00 AM PT|
|10:00 AM||Welcome and PCNA Presidential Address
Kim Newlin, RN, MS, CNS, ANP
|10:20 AM||Virtual Symposium Overview and Pre-Assessment|
|10:30 AM||SGLT2 Inhibitors and Cardiovascular Outcomes
Darren McGuire, MD, MHSc; Cindy Lamendola RN, MS, ANP
|11:30 AM||GLP1 Agonists and Cardiovascular Outcomes
Eryn Bryant, RN, MS, ANP
|12:15 PM||Non-CE Symposium from Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA - The Continuum of Heart Failure|
|1:15 PM||Inflammation and Cardiovascular Disease: Understanding the Relationship
Donna Arnett, PhD
|2:00 PM||Oral Abstract Presentation
Innovative Project: Matters of the Heart – Navigating Resources to Assist Patients in Managing Cardiovascular Conditions
|2:30 PM||Current Trends in the Diagnosis and Management of Ischemic Heart Disease and Microvascular Angina
Eileen Handberg, PhD, ARNP-BC, FACC
|3:15 PM||Day 1 Post-Assessment and Wrap-Up|
|THURSDAY, MAY 21|
|Start at 10:15 AM ET, 9:15 AM CT, 8:15 AM MT, and 7:15 AM PT|
|9:15 AM||Welcome: Key Learnings from Day 1 and Pre-Assessment Day 2|
|9:20 AM||Product Theater from Amgen
Cardiovascular Patient Cases
Janice McAlister, DNP, APRN, CLS
|10:15 AM||Sex Differences in Prevention and Management of Heart Failure
Mariell Jessup, MD
|11:00 AM||Lipid Management in 2020: The Role of Non-Statin Therapies
Susan Halli-Demeter, RN, DNP, CLS
|12:00 PM||Product Theater from Esperion - NEXLETOL: A New, Oral, Nonstatin Therapy for Lowering LDL-C
Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA
|1:00 PM||Oral Poster Presentation
Original Research: Symptoms, Functional Capacity, and Skeletal Muscle in Persons with Heart Failure with Preserved Ejection Fraction
Brittany Butts PhD, RN
|1:15 PM||Optimal Nutrition for Cardiovascular Risk Reduction: What should we eat now?
Catherine Christie, PhD, RDN, LDN, FADA, FPCNA
|2:05 PM||Review of COVID 19: Epidemiology and Cardiovascular Considerations
Yvonne Commodore-Mensah PhD, MHS, RN FAHA, FPCNA
|2:50 PM||Day 2 Post-learning assessment and Wrap up|
PCNA would like to thank the following sponsors for helping to make our program possible:
- Amgen, Inc.
- AstraZeneca Pharmaceuticals
- Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA
- Esperion Therapeutics, Inc.
- Novo Nordisk, Inc.
- Pfizer-Merck Alliance
- American Heart Association Scientific Councils
- Cardiovascular and Stroke Nursing
- Epidemiology and Prevention
- Lifestyle and Cardiometabolic Health
- Kidney in Cardiovascular Disease
Questions? Contact us.
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.